Scarica l'app Stockscreener
19.09
0.18%
-0.035
Dopo l'orario di chiusura:
19.09
0.005
+0.03%
Precedente Chiudi:
$19.12
Aprire:
$19.05
Volume 24 ore:
345.08K
Relative Volume:
0.55
Capitalizzazione di mercato:
$1.43B
Reddito:
$122.87M
Utile/perdita netta:
$-73.68M
Rapporto P/E:
-19.47
EPS:
-0.9803
Flusso di cassa netto:
$-39.27M
1 W Prestazione:
+7.58%
1M Prestazione:
+11.74%
6M Prestazione:
+46.69%
1 anno Prestazione:
+39.31%
Intervallo 1D:
$18.77
$19.20
Intervallo di 1 settimana:
$17.69
$19.98
Portata 52W:
$9.03
$19.98
Zymeworks Inc. Stock (ZYME) Company Profile
Nome
Zymeworks Inc.
Settore
Industria
Telefono
604-678-1388
Indirizzo
1385 West 8th Avenue, Suite 540, Vancouver, BC
Confronta ZYME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
19.09 | 1.45B | 122.87M | -73.68M | -39.27M | -0.9803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-24 | Ripresa | Wells Fargo | Equal Weight |
| 2025-10-14 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-10-10 | Iniziato | B. Riley Securities | Buy |
| 2025-05-20 | Iniziato | TD Cowen | Buy |
| 2024-12-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-11-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | Ripresa | Wells Fargo | Overweight |
| 2023-01-04 | Reiterato | H.C. Wainwright | Neutral |
| 2022-12-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | Ripresa | Wells Fargo | Overweight |
| 2022-05-05 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-03-15 | Iniziato | Evercore ISI | Outperform |
| 2021-12-10 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | Ripresa | Guggenheim | Neutral |
| 2021-10-07 | Iniziato | Jefferies | Hold |
| 2021-03-31 | Iniziato | Credit Suisse | Outperform |
| 2021-02-25 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | Ripresa | H.C. Wainwright | Buy |
| 2021-01-25 | Downgrade | Citigroup | Buy → Neutral |
| 2020-09-29 | Ripresa | JP Morgan | Neutral |
| 2020-08-06 | Iniziato | SVB Leerink | Outperform |
| 2020-01-10 | Iniziato | Wolfe Research | Outperform |
| 2019-12-09 | Iniziato | JP Morgan | Neutral |
| 2019-11-25 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-20 | Iniziato | Guggenheim | Buy |
| 2019-09-30 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | Iniziato | Stifel | Buy |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2018-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2018-03-19 | Iniziato | Raymond James | Outperform |
Mostra tutto
Zymeworks Inc. Borsa (ZYME) Ultime notizie
How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Volume & Comprehensive Market Scan Reports - newser.com
Will Zymeworks Inc. stock gain from strong economyQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
How to use Fibonacci retracement on Zymeworks Inc.Quarterly Market Summary & Real-Time Volume Analysis Alerts - newser.com
Custom strategy builders for tracking Zymeworks Inc.Trade Risk Assessment & Verified Swing Trading Watchlists - newser.com
Why Zymeworks Inc. (ZA8) stock could outperform next yearQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
How Zymeworks Inc. (ZA8) stock stacks up against competitors2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Why Zymeworks Inc. stock is in analyst buy zoneWatch List & Verified Momentum Stock Alerts - newser.com
Is Zymeworks Inc. (ZA8) stock nearing a technical breakout2025 Price Targets & Smart Allocation Stock Reports - newser.com
Will Zymeworks Inc. stock attract ESG investorsLong Setup & Consistent Growth Stock Picks - newser.com
Is Zymeworks Inc. (ZA8) stock cheap vs fundamentalsJuly 2025 Highlights & Real-Time Buy Signal Notifications - newser.com
Zymeworks, Inc. Hits New 52-Week High at $19.98 - Markets Mojo
Zymeworks Inc. (NASDAQ:ZYME) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Zymeworks (NASDAQ:ZYME) Reaches New 52-Week HighStill a Buy? - MarketBeat
Zymeworks stock hits 52-week high at $19.87 By Investing.com - Investing.com Australia
Applying Elliott Wave Theory to Zymeworks Inc.Market Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
How Zymeworks Inc. stock compares to market leadersJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com
Is now a turning point for Zymeworks Inc.Index Update & Fast Entry High Yield Stock Tips - newser.com
Will Zymeworks Inc. stock sustain high P E ratiosGap Down & Fast Entry and Exit Trade Plans - newser.com
What sentiment indicators say about Zymeworks Inc. stock2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Zymeworks stock hits 52-week high at $19.87 - Investing.com
Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Can Zymeworks Inc. stock resist market sell offsTrend Reversal & Reliable Trade Execution Plans - newser.com
Zymeworks (ZYME) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Zymeworks (ZYME) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
Zymeworks (ZYME) Price Target Increased by 12.22% to 25.24 - Nasdaq
Is Zymeworks Inc. forming a bottoming baseJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
Zymeworks (NYSE:ZYME) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Zymeworks (NASDAQ:ZYME) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Zymeworks to Engage with Investors at Key Conferences - TipRanks
Zymeworks Inc. Azioni (ZYME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):